Literature DB >> 16826241

Aqueous humour levels of cytokines are correlated to vitreous levels and severity of macular oedema in branch retinal vein occlusion.

H Noma1, H Funatsu, M Yamasaki, H Tsukamoto, T Mimura, T Sone, T Hirayama, H Tamura, H Yamashita, A Minamoto, H K Mishima.   

Abstract

AIM: To investigate whether the aqueous levels of vascular endothelial growth factor (VEGF) and interleukin-6 (IL-6) are correlated to the vitreous levels of these substances and to the severity of macular oedema in branch retinal vein occlusion (BRVO).
METHODS: Aqueous and vitreous samples were obtained during cataract and vitreous surgery from 24 patients (24 eyes) with macular oedema in BRVO. The VEGF and IL-6 levels in aqueous humour, vitreous fluid, and plasma were determined by enzyme-linked immunosorbent assay. The degree of retinal ischaemia was evaluated in terms of the area of capillary nonperfusion using the Scion Image. The severity of macular oedema was evaluated using the OCT.
RESULTS: The aqueous level of VEGF was significantly correlated with the vitreous level of VEGF (P<0.0001). Vitreous levels of VEGF and IL-6 were significantly correlated with the nonperfusion area of BRVO (P<0.0001, P=0.0061, respectively), as were the aqueous levels of VEGF and IL-6 (P<0.0001, P=0.0267, respectively). Furthermore, the vitreous levels of VEGF and IL-6 and the aqueous level of VEGF were significantly correlated with the severity of macular oedema of BRVO (P=0.0001, P=0.0331, P=0.0272, respectively).
CONCLUSION: Our results suggest that the aqueous level of VEGF may reflect its vitreous level. Measurement of the aqueous level of VEGF may be clinically useful to indicate the severity of macular oedema with BRVO.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16826241     DOI: 10.1038/sj.eye.6702498

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  79 in total

Review 1.  Use of bevacizumab for macular edema secondary to branch retinal vein occlusion: a systematic review.

Authors:  Taygan Yilmaz; Miguel Cordero-Coma
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-04-27       Impact factor: 3.117

2.  Visual acuity following intravitreal bevacizumab for macular edema associated with retinal vein occlusion.

Authors:  Masafumi Ota; Akitaka Tsujikawa; Kazuaki Miyamoto; Atsushi Sakamoto; Tomoaki Murakami; Nagahisa Yoshimura
Journal:  Jpn J Ophthalmol       Date:  2010-12-30       Impact factor: 2.447

3.  Aqueous humor inflammatory cytokine levels and choroidal thickness in patients with macular edema associated with branch retinal vein occlusion.

Authors:  Yerim An; Sung Pyo Park; Yong-Kyu Kim
Journal:  Int Ophthalmol       Date:  2021-03-19       Impact factor: 2.031

Review 4.  Growth Factors, Oxidative Damage, and Inflammation in Exfoliation Syndrome.

Authors:  Teresa Borrás
Journal:  J Glaucoma       Date:  2018-07       Impact factor: 2.503

5.  Association of electroretinogram and morphological findings in branch retinal vein occlusion with macular edema.

Authors:  Hidetaka Noma; Hideharu Funatsu; Seiyo Harino; Takeshi Sugawara; Tatsuya Mimura; Katsunori Shimada
Journal:  Doc Ophthalmol       Date:  2011-07-30       Impact factor: 2.379

6.  Alterations in the intraocular cytokine milieu after intravitreal bevacizumab.

Authors:  Farzin Forooghian; Peter J Kertes; Kenneth T Eng; Elvira Agrón; Emily Y Chew
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-12-10       Impact factor: 4.799

7.  [Cytokine determination from vitreous samples in retinal vascular diseases].

Authors:  M Pfister; F H Koch; J Cinatl; F Rothweiler; R Schubert; P Singh; H Ackermann; M J Koss
Journal:  Ophthalmologe       Date:  2013-08       Impact factor: 1.059

8.  Paracrine potential of fibroblasts exposed to cigarette smoke extract with vascular growth factor induction.

Authors:  Craig M Berchtold; Adam Coughlin; Zachary Kasper; Susan L Thibeault
Journal:  Laryngoscope       Date:  2013-03-13       Impact factor: 3.325

9.  Visual prognostic value of photopic negative response and optical coherence tomography in central retinal vein occlusion after anti-VEGF treatment.

Authors:  Chan Hee Moon; Sang Il Ahn; Young-Hoon Ohn; Hyung Woo Kwak; Tae Kwann Park
Journal:  Doc Ophthalmol       Date:  2013-03-15       Impact factor: 2.379

10.  Influence of retinal ischemia on macular function after pars plana vitrectomy for macular edema with branch retinal vein occlusion.

Authors:  Hidetaka Noma; Katsunori Shimada; Tatsuya Mimura
Journal:  Int Ophthalmol       Date:  2013-03-29       Impact factor: 2.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.